Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Description

This research study is testing combination Blue-light photodynamic therapy and Sonidegib as a possible treatment for people with multiple basal cell carcinoma lesions. Basal cell carcinoma lesions are typically treated by freezing the lesion or surgically removing the lesion. These types of treatment can cause scarring. Photodynamic therapy uses light along with a drug applied to the skin to kill the cancer cells and cause them to break apart. The light used can cause the skin to feel warm, but does not cause scarring.

Conditions

Basal Cell Carcinoma (BCC)

Study Overview

Study Details

Study overview

This research study is testing combination Blue-light photodynamic therapy and Sonidegib as a possible treatment for people with multiple basal cell carcinoma lesions. Basal cell carcinoma lesions are typically treated by freezing the lesion or surgically removing the lesion. These types of treatment can cause scarring. Photodynamic therapy uses light along with a drug applied to the skin to kill the cancer cells and cause them to break apart. The light used can cause the skin to feel warm, but does not cause scarring.

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Condition
Basal Cell Carcinoma (BCC)
Intervention / Treatment

-

Contacts and Locations

Phoenix

Medical Dermatology Specialists, Phoenix, Arizona, United States, 85006

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Nathalie Zeitouni,

    Nathalie Zeitouni, MD, PRINCIPAL_INVESTIGATOR, Medical Dermatology Specialists

    Study Record Dates

    2026-12-01